Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Docosahexaenoic acid for reading, cognition and behavior in children aged 7-9 years: a randomized, controlled trial (the DOLAB Study).

Richardson AJ, Burton JR, Sewell RP, Spreckelsen TF, Montgomery P.

PLoS One. 2012;7(9):e43909. doi: 10.1371/journal.pone.0043909. Epub 2012 Sep 6.

2.

Docosahexaenoic acid for reading, working memory and behavior in UK children aged 7-9: A randomized controlled trial for replication (the DOLAB II study).

Montgomery P, Spreckelsen TF, Burton A, Burton JR, Richardson AJ.

PLoS One. 2018 Feb 20;13(2):e0192909. doi: 10.1371/journal.pone.0192909. eCollection 2018.

3.

Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.

Widenhorn-Müller K, Schwanda S, Scholz E, Spitzer M, Bode H.

Prostaglandins Leukot Essent Fatty Acids. 2014 Jul-Aug;91(1-2):49-60. doi: 10.1016/j.plefa.2014.04.004. Epub 2014 May 28.

PMID:
24958525
4.

Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.

Milte CM, Parletta N, Buckley JD, Coates AM, Young RM, Howe PR.

Nutrition. 2012 Jun;28(6):670-7. doi: 10.1016/j.nut.2011.12.009. Epub 2012 Apr 25.

PMID:
22541055
5.

Low blood long chain omega-3 fatty acids in UK children are associated with poor cognitive performance and behavior: a cross-sectional analysis from the DOLAB study.

Montgomery P, Burton JR, Sewell RP, Spreckelsen TF, Richardson AJ.

PLoS One. 2013 Jun 24;8(6):e66697. doi: 10.1371/journal.pone.0066697. Print 2013. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/26c6b13f-b83a-4a3f-978a-c09d8ccf1ae2.

6.

Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.

Bos DJ, Oranje B, Veerhoek ES, Van Diepen RM, Weusten JM, Demmelmair H, Koletzko B, de Sain-van der Velden MG, Eilander A, Hoeksma M, Durston S.

Neuropsychopharmacology. 2015 Sep;40(10):2298-306. doi: 10.1038/npp.2015.73. Epub 2015 Mar 19.

7.

Increased Erythrocyte Eicosapentaenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Randomized Controlled Three-Way Crossover Trial.

Milte CM, Parletta N, Buckley JD, Coates AM, Young RM, Howe PR.

J Atten Disord. 2015 Nov;19(11):954-64. doi: 10.1177/1087054713510562. Epub 2013 Nov 8.

PMID:
24214970
9.

Fatty acids and sleep in UK children: subjective and pilot objective sleep results from the DOLAB study--a randomized controlled trial.

Montgomery P, Burton JR, Sewell RP, Spreckelsen TF, Richardson AJ.

J Sleep Res. 2014 Aug;23(4):364-88. doi: 10.1111/jsr.12135. Epub 2014 Mar 8.

10.

A double-blind, placebo-controlled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population.

Kirby A, Woodward A, Jackson S, Wang Y, Crawford MA.

Res Dev Disabil. 2010 May-Jun;31(3):718-30. doi: 10.1016/j.ridd.2010.01.014. Epub 2010 Feb 18.

PMID:
20171055
11.

Omega 3/6 fatty acids for reading in children: a randomized, double-blind, placebo-controlled trial in 9-year-old mainstream schoolchildren in Sweden.

Johnson M, Fransson G, Östlund S, Areskoug B, Gillberg C.

J Child Psychol Psychiatry. 2017 Jan;58(1):83-93. doi: 10.1111/jcpp.12614. Epub 2016 Aug 22.

PMID:
27545509
12.

DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial.

Stonehouse W, Conlon CA, Podd J, Hill SR, Minihane AM, Haskell C, Kennedy D.

Am J Clin Nutr. 2013 May;97(5):1134-43. doi: 10.3945/ajcn.112.053371. Epub 2013 Mar 20.

PMID:
23515006
14.

Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.

Gillies D, Sinn JKh, Lad SS, Leach MJ, Ross MJ.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD007986. doi: 10.1002/14651858.CD007986.pub2. Review.

PMID:
22786509
15.

The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population.

Stough C, Downey L, Silber B, Lloyd J, Kure C, Wesnes K, Camfield D.

Neurobiol Aging. 2012 Apr;33(4):824.e1-3. doi: 10.1016/j.neurobiolaging.2011.03.019. Epub 2011 May 4.

PMID:
21531481
16.

Prenatal supplementation with DHA improves attention at 5 y of age: a randomized controlled trial.

Ramakrishnan U, Gonzalez-Casanova I, Schnaas L, DiGirolamo A, Quezada AD, Pallo BC, Hao W, Neufeld LM, Rivera JA, Stein AD, Martorell R.

Am J Clin Nutr. 2016 Oct;104(4):1075-1082. Epub 2016 Sep 7.

17.

Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.

Sarmento Vasconcelos V, Macedo CR, de Souza Pedrosa A, Pereira Gomes Morais E, Porfírio GJ, Torloni MR.

Cochrane Database Syst Rev. 2016 Aug 17;(8):CD011014. doi: 10.1002/14651858.CD011014.pub2. Review.

PMID:
27536971
18.

Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial.

Smithers LG, Collins CT, Simmonds LA, Gibson RA, McPhee A, Makrides M.

Am J Clin Nutr. 2010 Mar;91(3):628-34. doi: 10.3945/ajcn.2009.28603. Epub 2010 Jan 6.

PMID:
20053878
20.

Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.

Zwi M, Jones H, Thorgaard C, York A, Dennis JA.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD003018. doi: 10.1002/14651858.CD003018.pub3. Review.

PMID:
22161373

Supplemental Content

Support Center